Teruo Yamauchi

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.7K citations · Full text

Chemotherapy Versus Placebo, Breast Oncology, Oncology +7

Vitamin E δ-Tocotrienol Augments the Antitumor Activity of Gemcitabine and Suppresses Constitutive NF-κB Activation in Pancreatic Cancer

Kazim Husain, R François, Teruo Yamauchi et al. · Molecular Cancer Therapeutics · 2011 · 102 citations

Vitamin E, Tumor Biology, Antitumor Activity +12

Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment

Akina Natori, Toru Ogata, Masahiko Sumitani et al. · Clinical Cancer Research · 2015 · 38 citations · Full text

Characteristics of taste alterations in people receiving taxane-based chemotherapy and their association with appetite, weight, and quality of life

Mikiko Kaizu, Hiroko Komatsu, Hideko Yamauchi et al. · Supportive Care in Cancer · 2021 · 33 citations · Full text

Differential impact of fosaprepitant on infusion site adverse events between cisplatin- and anthracycline-based chemotherapy regimens.

Takeo Fujii, Naoki Nishimura, Kevin Y. Urayama et al. · PubMed · 2015 · 31 citations